Product Information:

ZOLID 45mg Tablets contain Pioglitazone Hydrochloride 45mg, the maximum approved dose of a thiazolidinedione (TZD) class oral antidiabetic agent. It works by activating peroxisome proliferator-activated receptor-gamma (PPAR-γ) in adipose tissue, skeletal muscle, and liver, thereby significantly improving insulin sensitivity and reducing insulin resistance—the core defect in type 2 diabetes mellitus.

This high-strength formulation is reserved for patients who require maximal insulin-sensitizing therapy and have not achieved glycemic targets on lower doses.

Uses of (ZOLID 45MG TABLETS):

1. Add-on therapy for type 2 diabetes mellitus in adults uncontrolled on lower doses of pioglitazone or other antidiabetics
2. Patients with severe insulin resistance (e.g., obesity, PCOS-related diabetes)
3. Combination with metformin, sulfonylureas, or basal insulin when intensive glycemic control is needed

Key Benefits of (ZOLID 45MG TABLETS):

1. Provides the strongest insulin-sensitizing effect among pioglitazone doses
2. Reduces HbA1c by up to 1.5% in clinical studies
3. May help preserve pancreatic beta-cell function over time
4. Once-daily dosing improves adherence

How To Use (ZOLID 45MG TABLETS):

1. Take once daily, with or without food, at the same time each day.
2. Swallow whole with water—do not crush or chew.
3. Typical use:
4. Start at 15mg or 30mg daily, then escalate to 45mg once daily only if HbA1c remains above target after 8–12 weeks
5. Continue diet, exercise, and regular blood glucose monitoring.

When Not to Use (ZOLID 45MG TABLETS):

Do not use if you have:

1. Type 1 diabetes or diabetic ketoacidosis
2. Active liver disease or ALT >2.5× upper limit
3. History of bladder cancer (pioglitazone increases risk, especially at 45mg)
4. Heart failure (NYHA Class III or IV)
5. Hypersensitivity to pioglitazone or any excipients

⚠️ Important: The 45mg dose carries the highest risk of side effects, including bladder cancer and fluid retention. Use only when benefits clearly outweigh risks.

Side Effects of (ZOLID 45MG TABLETS):

Common:

1. Significant weight gain (average 2–4 kg)
2. Moderate to severe edema (swelling in legs, ankles, or abdomen)
3. Headache, fatigue

Less common:

1. Bone fractures (especially in postmenopausal women)
2. Mild anemia
3. Elevated liver enzymes

Serious (require vigilant monitoring):

1. Worsening or new-onset heart failure (shortness of breath, rapid weight gain, orthopnea)—discontinue immediately
2. Bladder cancer (hematuria, dysuria, pelvic pain)—risk is dose- and duration-dependent (>1 year use)
3. Hepatotoxicity (jaundice, dark urine, abdominal pain)—monitor LFTs regularly
4. Seek emergency care if signs of heart failure, blood in urine, or yellowing of skin/eyes occur.

Dosage: (ZOLID 45MG TABLETS):

1. Adults: 45mg once daily (maximum approved dose)
2. Not for initiation—only after failure of 15–30mg doses
3. Elderly or hepatic impairment: Avoid unless closely monitored
4. Renal impairment: No dose adjustment needed (not renally excreted)

Who It’s For (ZOLID 45MG TABLETS):

Adults with severe insulin resistance and persistently high HbA1c despite optimal therapy with lower pioglitazone doses or other agents—and who have no contraindications to TZDs.

Warnings & Precautions:

1. Contraindicated in active or prior bladder cancer
2. Monitor liver function tests (LFTs) before and during therapy
3. Assess heart failure symptoms at every visit
4. Screen annually for hematuria or urinary symptoms
5. Avoid in postmenopausal women with osteoporosis (↑ fracture risk)
6. Discontinue if macular edema develops

Drug Interactions:

1. Gemfibrozil: ↑ Pioglitazone levels—avoid combination
2. Rifampin: ↓ Pioglitazone efficacy—monitor glucose closely
3. Insulin or sulfonylureas: ↑ Risk of hypoglycemia
4. Always inform your doctor about all medications and supplements.

Additional Information:

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date. Available by prescription only in Pakistan.